• Home
  • Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification.

Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification.

Author List
Deans RM, Morgens DW, Ökesli A, Pillay S, Horlbeck MA, Kampmann M, Gilbert LA, Li A, Mateo R, Smith M, Glenn JS, Carette JE, Khosla C, Bassik MC
Publication
Nature chemical biology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1199160
Publication Year
2016
PubMed ID
27018887
Publication Title
Deans RM, Morgens DW, Ökesli A, Pillay S, Horlbeck MA, Kampmann M, Gilbert LA, Li A, Mateo R, Smith M, Glenn JS, Carette JE, Khosla C, Bassik MC. Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification. Nat Chem Biol. 2016 May; 12(5):361-6.